Microbicidal properties of leukocyte-and platelet-rich plasma/fibrin (L-prp/l-prf): New perspectives.

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 2, 2012, Pages 43-52

  Cieslik Bielecka, A ^a   Dohan Ehrenfest, D M ^b,c   Lubkowska, A ^d,e   Bielecki, Tomasz ^a,f  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Chonnam National University   (South Korea)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF SZCZECIN   (Poland)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

^f Department of Laryngology and ENT Oncology   (Poland)

Author keywords

Leukocyte; Platelet concentrate; PRF (Platelet Rich Fibrin); PRP (Platelet Rich Plasma)

Indexed keywords

ALPHA DEFENSIN; ANTIINFECTIVE AGENT; FIBRIN; SIGNAL PEPTIDE;

BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL VIABILITY; NEUTROPHIL; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE RICH PLASMA; WOUND HEALING;

ALPHA-DEFENSINS; ANTI-INFECTIVE AGENTS; BLOOD PLATELETS; ESCHERICHIA COLI; FIBRIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL VIABILITY; NEUTROPHILS; PLATELET-RICH PLASMA; WOUND HEALING;

EID: 84878820449     PISSN: 0393974X     EISSN: 17246083     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Bielecki T, Dohan Ehrenfest DM, Everts PA, Wiczkowski A. The Role of Leukocytes from L-PRP/L-PRF in Wound Healing and Immune Defense: New Perspectives. Curr Pharm Biotechnol (In Press).
2. Everts PA, Overdevest EP, Jakimowicz JJ et al. The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review. Surg Endosc 2007; 21:2063-2068.
3. Ohki Y, Heissig B, Sato Y et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005; 19:2005-2007.
4. Toulon A, Breton L, Taylor KR et al. A role for human skin-resident T cells in wound healing. J Exp Med 2009; 206:743-750.
5. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27:158-167.
6. Dohan Ehrenfest DM, Bielecki T, Mishra A et al. In Search of a Consensus Terminology in the Field of Platelet Concentrates for Surgical Use: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), Fibrin Gel Polymerization and Leukocytes. Curr Pharm Biotechnol (In Press).
7. Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol 2010; 81:546-555.
8. Sammartino G, Dohan Ehrenfest DM, Carile F, Tia M, Bucci P. Prevention of Hemorrhagic Complications After Dental Extractions Into Open Heart Surgery Patients Under Anticoagulant Therapy: The Use of Leukocyte-and Platelet-Rich Fibrin. Journal of Oral Implantology 2011; 37:681-690.
9. Garcia RV, Gabrielli MAC, Hochuli-Vieira E et al. Effect of Platelet-Rich Plasma on Peri-Implant Bone Repair: A Histologic Study in Dogs. Journal of Oral Implantology 2010; 36:281-290.
10. Kesler G, Shvero DK, Tov YS, Romanos G. Platelet Derived Growth Factor Secretion and Bone Healing After Er:YAG Laser Bone Irradiation. Journal of Oral Implantology 2011; 37:195-204.
11. Oktay EO, Demiralp B, Senel S, Akman AC, Eratalay K, Akincibay H. Effects of Platelet-Rich Plasma and Chitosan Combination on Bone Regeneration in Experimental Rabbit Cranial Defects. Journal of Oral Implantology 2010; 36:175-184.
12. Rutkowski JL, Johnson DA, Radio NM, Fennell JW. Platelet Rich Plasma to Facilitate Wound Healing Following Tooth Extraction. Journal of Oral Implantology 2010; 36:11-23.
13. Trindade-Suedam IK, de Morais J, Faeda RS et al. Bioglass Associated With Leukocyte-Poor Platelet-Rich Plasma in the Rabbit Maxillary Sinus: Histomorphometric, Densitometric, and Fractal Analysis. Journal of Oral Implantology 2010; 36:333-344.
14. Rocha FS, Ramos LMA, Batista JD, Zanetta-Barbosa D, Ferro EAV, Dechichi P. Bovine Anorganic Bone Graft Associated with Platelet-Rich Plasma: Histologic Analysis in Rabbit Calvaria. Journal of Oral Implantology 2011; 37:511-518.
15. Ota-Tsuzuki C, Datte CE, Nomura KA, Cardoso LAG, Shibli JA. Influence of Titanium Surface Treatments on Formation of the Blood Clot Extension. Journal of Oral Implantology 2011; 37:641-647.
16. Ahn SJ, Leesungbok R, Lee SW. Histomorphometric Analysis and Removal Torque of Small Diameter Implants With Alternative Surface Treatments and Different Designs. Journal of Oral Implantology 2010; 36:263-272.
17. Dohan Ehrenfest DM. Fractal Patterns Applied to Implant Surface: Definitions and Perspectives. Journal of Oral Implantology 2011; 37:506-509. P
18. Dohan Ehrenfest DM, Vazquez L, Park YJ, Sammartino G, Bernard JP. Identification Card and Codification of the Chemical and Morphological Characteristics of 14 Dental Implant Surfaces. Journal of Oral Implantology 2011; 37:525-542. R
19. Malchiodi L, Corrocher G, Cucchi A, Ghensi P, Bissolotti G, Nocini PF. Long-Term Results of Immediately Loaded Fast Bone Regeneration-Coated Implants Placed in Fresh Extraction Sites in the Upper Jaw. Journal of Oral Implantology 2010; 36:251-262.
20. Olate S, Netto H, Kluppel LE, Mazzonetto R, de Albergaria-Barbosa JR. Mineralized Tissue Formation Associated With 2 Different Dental Implant Designs: Histomorphometric Analyses Performed in Dogs. Journal of Oral Implantology 2011; 37:319-324.
21. Mangano C, Piattelli A, Tettamanti L et al. Engineered Bone by Autologous Osteoblasts on Polymeric Scaffolds in Maxillary Sinus Augmentation: Histologic Report. Journal of Oral Implantology 2010; 36:491-496.
22. Amet EM. Management of Unscheduled Anterior Tooth or Prosthesis Loss With Extraction and Immediate Implant Placement: A Clinical Report. Journal of Oral Implantology 2010; 36:209-218.
23. Kusek ER. Immediate Implant Placement Into Infected Sites: Bacterial Studies of the Hydroacoustic Effects of the YSGG Laser. Journal of Oral Implantology 2011; 37:205-211.
24. Linde A, Ross CR, Davis EG, Dib L, Blecha F, Melgarejo T. Innate immunity and host defense peptides in veterinary medicine. J Vet Intern Med 2008; 22:247-265.
25. Scott MG, Hancock RE. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 2000; 20:407-431.
26. Sima P, Trebichavsky I, Sigler K. Mammalian antibiotic peptides. Folia Microbiol (Praha) 2003; 48:123-137.
27. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997; 25:951-968; quiz 969-970.
28. Moran CJ, Arenberg DA, Huang CC et al. RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res 2002; 8:3803-3812.
29. Sadek MI, Sada E, Toossi Z, Schwander SK, Rich EA. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 1998; 19:513-521.
30. Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect Immun 1999; 67:3452-3460.
31. Zucker MB, Katz IR. Platelet factor 4: production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med 1991; 198:693-702.
32. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70:6524-6533.
33. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg Br 2007; 89:417-420.
34. Dohan Ehrenfest DM, Bielecki T, Del Corso M, Inchingolo F, Sammartino G. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A 2010; 95:1280-1282.
35. Dohan Ehrenfest DM. How to optimize the preparation of leukocyte-and platelet-rich fibrin (L-PRF, Choukroun’s technique) clots and membranes: introducing the PRF Box. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110:275-278; author reply 278-280.
36. Dohan Ehrenfest DM, Bielecki T, Jimbo R et al. Do the Fibrin Architecture and Leukocyte Content Influence the Growth Factor Release of Platelet Concentrates? An Evidence-Based Answer Comparing a Pure Platelet-Rich Plasma (P-PRP) Gel and a Leukocyte-and Platelet-Rich Fibrin (L-PRF). Curr Pharm Biotechnol (In Press).
37. Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009; 27:63-69.
38. Levy O, Sisson RB, Fryer HE et al. Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils. Transplantation 2002; 73:1522-1526.
39. Uvell H, Engstrom Y. A multilayered defense against infection: combinatorial control of insect immune genes. Trends Genet 2007; 23:342-349.
40. Hancock RE, Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 2002; 206:143-149.
41. Hancock RE, Scott MG. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 2000; 97:8856-8861.
42. Boman HG. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003; 254:197-215.
43. Wu Z, Hoover DM, Yang D et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A 2003; 100:8880-8885.
44. Semple CA, Rolfe M, Dorin JR. Duplication and selection in the evolution of primate beta-defensin genes. Genome Biol 2003; 4:R31.
45. Jia HP, Starner T, Ackermann M, Kirby P, Tack BF, McCray PB, Jr. Abundant human beta-defensin-1 expression in milk and mammary gland epithelium. J Pediatr 2001; 138:109-112.
46. Kaiser V, Diamond G. Expression of mammalian defensin genes. J Leukoc Biol 2000; 68:779-784.
47. Tunzi CR, Harper PA, Bar-Oz B et al. Beta-defensin expression in human mammary gland epithelia. Pediatr Res 2000; 48:30-35.
48. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276:5707-5713.
49. Diamond G, Bevins CL. Beta-Defensins: endogenous antibiotics of the innate host defense response. Clin Immunol Immunopathol 1998; 88:221-225.
50. Yasin B, Wang W, Pang M et al. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 2004; 78:5147-5156.
51. De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 2005; 27:1337-1347.
52. Niyonsaba F, Iwabuchi K, Someya A et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002; 106:20-26.
53. Rosenberger CM, Gallo RL, Finlay BB. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A 2004; 101:2422-2427.
54. Wang W, Owen SM, Rudolph DL et al. Activity of alpha-and theta-defensins against primary isolates of HIV-1. J Immunol 2004; 173:515-520.
55. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5:1317-1327.
56. Moriuchi H, Moriuchi M, Fauci AS. Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection. J Virol 2000; 74:6849-6855.
57. Calafat J, Janssen H, Tool A et al. The bactericidal/ permeability-increasing protein (BPI) is present in specific granules of human eosinophils. Blood 1998; 91:4770-4775.
58. Srivastava A, Casey H, Johnson N, Levy O, Malley R. Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease. Infect Immun 2007; 75:342-349.
59. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005; 25:1102-1111.
60. Striz I, Trebichavsky I. Calprotectin-a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004; 53:245-253.
61. Steinrauf LK, Shiuan D, Yang WJ, Chiang MY. Lysozyme association with nucleic acids. Biochem Biophys Res Commun 1999; 266:366-370.
62. Witholt B, Heerikhuizen HV, De Leij L. How does lysozyme penetrate through the bacterial outer membrane? Biochim Biophys Acta 1976; 443:534-544.
63. Rinder HM, Tracey JL, Rinder CS, Leitenberg D, Smith BR. Neutrophil but not monocyte activation inhibits P-selectin-mediated platelet adhesion. Thromb Haemost 1994; 72:750-756.
64. Peters MJ, Heyderman RS, Hatch DJ, Klein NJ. Investigation of platelet-neutrophil interactions in whole blood by flow cytometry. J Immunol Methods 1997; 209:125-135.
65. Neumann FJ, Marx N, Gawaz M et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997; 95:2387-2394.
66. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999; 106:391-399.
67. Cieslik-Bielecka, A. Estimation of an influence the autogenous growth factors on postoperative wound healing processes in animals and patients with double mandibular fracture, and patients with chronic wounds. Habilitation work. Medical University of Silesia, 2010; 6:1-164.